Related Experiment Video
Updated: Nov 20, 2025
Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Necrotizing Pancreatitis from Hypertriglyceridemia: More Severe Disease?
T K Maatman1, J A Westfall-Snyder2, E P Ceppa1
1Department of Surgery, Indiana University School of Medicine, 545 Barnhill Drive EH 519, Indianapolis, IN, 46202, USA.
Hypertriglyceridemia-induced necrotizing pancreatitis (HTG-NP) does not show increased severity, morbidity, or mortality compared to other causes of NP. This study found similar outcomes between HTG-NP and non-HTG NP patients.
Area of Science:
- Gastroenterology
- Endocrinology
- Critical Care Medicine
Background:
- Hypertriglyceridemia (HTG) causes necrotizing pancreatitis (NP) in up to 10% of cases.
- Clinical observations suggest HTG-NP is more severe, but objective data is limited.
Purpose of the Study:
- To evaluate and compare clinical outcomes in patients with HTG-NP versus NP from other etiologies.
- To test the hypothesis that HTG-NP is associated with increased severity, morbidity, and mortality.
Main Methods:
- A case-control study of 676 NP patients (2005-2018) was conducted.
- HTG-NP was defined as serum triglycerides >1000 mg/dL without other causes.
- Propensity score matching (4:1 ratio) controlled for age, sex, and comorbidities.
Main Results:
- The incidence of HTG-NP was 5.8% (39 patients).
- No significant differences were observed in CT severity, necrosis, organ failure, or hospital length of stay between HTG-NP and non-HTG NP groups.
- Mortality rates were similar: 7.1% for non-HTG-NP and 7.7% for HTG-NP.
Conclusions:
- In this large series, HTG-NP demonstrated comparable disease severity, morbidity, and mortality to NP from other causes.
- The findings challenge the notion of inherently increased severity for HTG-NP.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Related Concept Videos
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:16Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...